Thermo Fisher’s
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
How much of Thermo Fisher's antibody data has been manipulated?
[ TL;DR: As of 3 June 2026, we have identified more than 450 images bearing signs of manipulation in verification data advertised by Thermo Fisher Scientific in its online primary antibodies catalog (+1 by Abcam). See the full repository of problematic images, curated by myself and Sholto David, here: Zenodo – Problematic images in vendor antibody verification data You are welcome to contribute new findings at this Google form.
Science sleuths uncover more than 100 suspicious images in Thermo Fisher antibody catalogue
Nature, Published online: 29 May 2026; doi:10.1038/d41586-026-01706-2Scientists have long worried about the reliability of commercial antibodies, and the latest findings have sparked fresh concerns.
A prognostic human brain network for diffuse midline glioma
Abstract Diffuse midline gliomas (DMGs) are near-universally lethal tumours of the childhood central nervous system1,2. In animal models, DMGs form brain-wide integrated networks through neuron-to-glioma synapses3,4,5,6 and glioma-to-glioma gap junctional coupling3. This extensive connectivity robustly promotes the growth and invasion of DMG3,4,5,6,7,8,9 and other glial malignancies10,11,12 through paracrine mechanisms and direct neuron-to-glioma synapses.
Whole-genome duplication shaped cell-type evolution in the vertebrate brain
Abstract The complex brains of vertebrates have more cell types than those of their closest relatives. Whole-genome duplications (WGDs) occurred during early vertebrate evolution1, but it is unclear whether the duplicated genes (ohnologues) facilitated cell-type evolution. Here using brain single-cell transcriptomes from five chordates—human2, mouse3, lizard4, lamprey5 and amphioxus—we report that many cell-type families with conserved core transcription factors in vertebrates do not show...